Eurotrials Brasil Consultores Cientificos Ltda   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Lisbon Portugal (1995)

Organization Overview

First Clinical Trial
2006
NCT01324934
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

brimonidine (alphagan) (1 trial)

Drugs in Phase 3 Trials (3)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)

glucosamine (1 trial)

meloxicam (mobic) (1 trial)

Drugs in Phase 2 Trials (2)

ruscus aculeatus (1 trial)

rutin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erythema (Phase 4)

Facies (Phase 4)

Osteoarthritis (Phase 3)

Stress, Psychological (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6